In this study, we examined the ability of soybean lipoxygenase to mediate the N-demethylation of imipramine and related drugs in the presence of hydrogen peroxide. Formaldehyde generation resulting from the N-demethylation of imipramine, a prototype drug, was found to depend on incubation time, and the concentration of the enzyme, imipramine, and hydrogen peroxide. Under optimal assay conditions, Vmax values of 14 to 18 nmol formaldehyde/min/nmol enzyme or 133 to 164 nmol formaldehyde/min/mg protein were observed. An inhibition of formaldehyde and desipramine formation by nordihydroguaiaretic acid con® rmed the lipoxygenase involvement. The blockade of the reaction by glutathione, dithiothreitol, butylated hydroxyanisole (BHA), and butylated hydroxytoluene (BHT) indicated the generation of a free radical intermediate from imipramine. Desipramine, trimipramine, clomipramine, and diltiazem, but not amitriptyline and doxepin, were also oxidized, albeit at a lower rate. Collectively, the evidence gathered in this study suggests, for the ® rst time, that tricyclic antidepressant drugs may undergo lipoxygenase-catalyzed N-demethylation.
Tricyclic antidepressants such as imipramine and closely related compounds represent a group of drugs most widely used today in the United States and other countries for the treatment of major depression. Their remarkable ef® cacy in alleviating depression is well established and an exploration of their possible use for the treatment of other psychiatric disorders is increasing. Signi® cant side effects of these drug are common. Besides central nervous system (CNS) and cardiovascular toxicity, a few reports have described a species-speci® c teratogenicity of these drugs in animals and debate continues over whether or not antidepressant drugs induce birth defects in human (Schardein 1985) .
Once absorbed, these drugs exhibit relatively long half-lives and are widely distributed in different tissues and undergo extensive oxidative metabolism. Imipramine, a prototype for this class, is mainly metabolized by two pathways: hydroxylation and N -dealkylation. The removal of one methyl group from the aliphatic side chain (mono-N -demethylation) results in the formation of desipramine (DI), an active metabolite also ef-® cacious for the treatment of mental depression, whereas the removal of both the methyl groups (di-N -demethylation) inactivates the drug by forming didesmethylimipramine (DDI). The role played by hepatic microsomal cytochrome P450 (P450) in N -demethylation of imipramine is well recognized (Brosen 1995; Brosen et al. 1986; Brosen, Skjelbo, and Nielsen 1996) . Some information is also available for this reaction in the brain tissue (Sequeira and Strobel 1995; Kawashima et al. 1996) . Besides N -demethylation, human and rat brain microsomal¯avincontaining monooxygenase (FMO) was reported to generate imipramine N -oxide, an inactive metabolite (Bhagwat et al. 1996a (Bhagwat et al. , 1996b ).
It appears that ourcurrent understanding of imipramine metabolism is far from complete. Furthermore, although the results have been inconclusive, several reports have implicated multiple forms of P450 (Birgersson et al. 1986; Skjelbo et al. 1991; Lemoine et al. 1993; Brosen 1995) in imipramine N -demethylation. Of these, CYP1A2, the principal form, accounts for only about 10 to 15% of total P450 content of human liver and it does not exhibit genetic polymorphism (Brosen 1995) . CYP1A2 displays broad substrate speci® city and many commonly ingested chemicals such as caffeine, and theophylline are also oxidized by the enzyme and, therefore, a competitive inhibition of imipramine oxidation by thesechemicals remains a strong possibility. Further support to the contention that non-P450 pathways may be involved comes from the observation that a pretreatment of rats with inducers of P450 such as phenobarbital and b -naphtho¯avone does not cause any major change in the rate of imipramine oxidation by the brain or liver microsomes (Sequeira and Strobel 1995) . The reactive metabolites of imipramine and related compounds are known to rapidly form inhibitory complexes with P450 during the ® rst cycle of enzyme activity (Bensoussan, Delaforge, and Mansuy 1995; Masubuchi et al. 1996) . In vivo, these complexes are stable, accumulate, and can be detected in liver microsomes even 36 hours after dosing. The identity of the enzyme(s) responsible for the metabolism of imipramine following thecomplex formation has not been established. This is an important consideration because imipramine therapy usually lasts for several weeks to months. A large (> 16fold) interindividual variation has been noted in the blood levels of imipramine in patients (Glassman et al. 1977; Brosen et al. 1986) , and the authors have concluded that this difference cannot be adequately explained by the known relatively small differences noted in the hepatic levels of these P450 isozymes. Ghersi-Egea et al. (1989) reported that the total P450 content in the rodent brain is only 0.6% of that found in the liver. Therefore, only a small amount of imipramine metabolism can be expected in the brain via the P450 pathway. The role of brain MFO in imipramine oxidation is a debatable issue because highly puri-® ed MFO does not catalyze this reaction if detergent is omitted from the incubation medium (Bhagwat et al. 1996a (Bhagwat et al. , 1996b . It is noteworthy that such an obligatory requirement for a detergent has not been reported in the literature for the oxidation of other chemicals by MFO and detergents, in general, either cause no effect or actually inhibit this enzyme (Ziegler 1993) . Thus, it appears that pathways other than P450 and FMO exist in vivo and therefore, an exploration of an alternate pathway(s) capable of oxidation of imipramine and related drugs is essential. Lipoxygenases (LOs) represent a group of non-heme iron proteins that are ubiquitous in plants and animals. Earlier, we reported the oxidation of model chemicals by LO in the presence of linoleic acid (Kulkarni and Cook 1988a) or hydrogen peroxide (H 2 O 2 ) (Kulkarni and Cook 1988b) . Subsequent studies have now established theco-oxidation of many hydroge n donors, drugs, mutagens, carcinogens, teratogens, pesticides, and industrial and other chemicals by LOs from different sources (see Kulkarni 1996 for references) . In contrast to a relatively very low P450 content, LO is abundant in the rat brain (Byczkowski, Ramgoolie, and Kulkarni 1992; Naidu, Naidu, and Kulkarni 1992) and human placenta (Joseph, Srinivasan, and Kulkarni 1993; Datta and Kulkarni 1994; Datta, Sherblom, and Kulkarni 1997) , the potential target tissues for imipramine toxicity. LO is also plentiful in the rat (Roy and Kulkarni 1994) and human liver (Roy and Kulkarni 1997) . Furthermore, imipramine is freely soluble in water and sparingly soluble in organic solvents such as acetone (Merck Index 1976) . In the absence of a speci® c transport mechanism, the partitioning of a therapeutic dose of imipramine from an aqueous phase (cytosol) to the lipid phase (microsomes) within thecell is dif® cult to envision. Therefore, in theory, the intracellular accessibility of imipramine is expected to be exclusive to the cytosolic LO (and other enzymes) and not to the microsomal P450 and MFO. Considering these points, we explored the possibility that a LO-mediated pathway may be involved by examining the ability of soybean LO (SLO), a model enzyme, to mediate the N -demethylation of drugs of this class. The results suggest, for the ® rst time, that SLO is capable of catalyzing the N -demethylation of these chemicals in the presence of H 2 O 2 .
MATERIALS AND METHODS

Materials
SLO (MW 108,000) Sigma type-V (760,000 Sigma units/mg protein), 37% H 2 O 2 , imipramine, desipramine, trimipramine, clomipramine, diltiazem, amitriptyline, doxepin, reduced glutathione (GSH), dithiothreitol (DTT), butylated hydroxyanisole (BHA), butylated hydroxytoluen e (BHT), and nor-dihydroguaiaretic acid (NDGA), were purchased from Sigma Chemical Co., St. Louis, MO. All other chemicals were of analytical grade and obtained commercially.
Enzyme Assay
Except noted otherwise, 200 nM SLO in 50 mM phosphate buffer, pH 6.5, was mixed with 2.5 mM imipramine. After 2 minutes preincubation at 37 ± C, the reaction was initiated by the addition of 0.5 mM H 2 O 2 (1.0 ml ® nal volume). Following incubation at 37 ± C, typically for 30 minutes, the reaction was terminated by the addition of 1.0 ml of 10% trichloroacetic acid (TCA). The formaldehyde accumulated in the reaction medium as a result of the N -demethylation of imipramine (or other test substrate) was estimated using the double strength Nash reagent. Control incubation media contained all the components except the enzyme. The data reported are corrected for the nonenzymatic reaction. Each experiment was repeated¸3 times and the experimental data are presented as mean § SEM.
High Performance Liquid Chromatography (HPLC)
A qualitative analysis of metabolites produced in the incubation media was performed by HPLC. Following incubation as described above, the reaction was terminated by the addition of 1.0 ml of cold chloroform:methanol (80:20, v/ v) mixture. After centrifugation at 3000 £ g for 10 minutes, the top aqueous layer was carefully removed and an 100-l l aliquot was directly injected into a 300 £ 3.9-mm C18 l Bondapak HPLC column (Waters) connected to a Perkin-Elmer LC235 diode array UV detector. A mobile phase consisting of acetonitrile:methanol: 10 mM K 2 HPO 4 , pH 7.0 (40:35:25) (Sequeria and Strobel 1995) was used to elute the components of the extract. A¯ow rate of 1.4 ml/min was maintained and the elution of products was monitored at 214 nm.
RESULTS
Formaldehyde accumulation in the reaction media was used as the index of the N -demethylation of imipramine. Several pilot experiments wereconducted to optimize the assay conditions
FIGURE 1
Effect of pH on imipramine oxidation by soybean lipoxygenase (SLO). The reaction medium consisted of 50 mM phosphate buffer of indicated pH, 2.5 mM imipramine, 200 nM SLO (absent in the control incubation), and 0.5 mM H 2 O 2 . The amount of formaldehyde accumulated was estimated by Nash reagent after 30 minutes incubation at 37 ± C.
The data represent mean § SD (n = 3).
(data not shown). The presence of active enzyme was necessary to observe the reaction and no signi® cant amount of formaldehyde was detected when either H 2 O 2 was absent or boiled enzyme preparation was used. Imipramine N -dealkylation was studied under a variety of experimental conditions. A maximum rate of formaldehyde production was observed when the pH of the incubation medium was in the acidic range (» 6.5 pH) (Figure 1 ). At the physiological pH of 7.4, the relative spe-ci® c activity was » 64% of the maximal rate noted at pH 6.5. Formaldehyde accumulation was dependent on the incubation time and the reaction was linear for 30 minutes (Figure 2A ). In view of this, the reaction was terminated at 30 minutes in all experiments. As shown in Figure 2B , the amount of formaldehyde formed increased with an increase in the enzyme concentration. However, linearity of the reaction was only observed when lower (< 200 nM) enzyme concentration was employed. The N -dealkylation of imipramine exhibited a dependence on the substrate concentration. The analysis of data by the Lineweaver-Burk plots ( Figure 2C ) yielded an apparent K M value of 0.66 mM for imipramine and an apparent V max value of 14.4 nmol formaldehyde/min/nmol enzyme or 133 nmol formaldehyde/min/mg enzyme. From similar experiments conducted in the presence of varying concentration of H 2 O 2 ( Figure 2D ), an apparent K M value of 116 l M was obtained for H 2 O 2 . These experiments yielded an apparent V max value of 17.7 nmol formaldehyde/min/nmol enzyme or 164 nmol formaldehyde/min/mg enzyme. Taken together, these results suggest an enzymatic nature of the reaction. The metabolites of imipramine generated during the reaction were resolved by HPLC. The data presented in Figure 3 indicate that desipramine is the principal metabolite resulting from imipramine N -demethylation catalyzed by SLO. The data given in Table 1 indicate that the enzymatic formaldehyde production from imipramine declined when NDGA, a classical inhibitor of lipoxygenase, was included in the reaction medium.
As expected, the presence of NDGA also depressed the amount of desipramine accumulated into the reaction mixture ( Figure  3F ) as compared to that in its absence ( Figure 3E ). BHT or BHA (Table 1 ) also inhibited the reaction signi® cantly, suggesting an involvement of free radicals in the reaction. Similarly, inclusion of reducing agents such as GSH and DTT in the reaction media also blocked the reaction in a concentration-dependent manner (Table 1) , as expected. The question of whether or not Assays were performed at 37 ± C for 30 minutes using incubation medium (1.0 ml ® nal volume) containing 200 nM SLO, 2.5 mM imipramine, and 0.5 mM H 2 O 2 in 50 mM phosphate buffer, pH 6.5. See Materials and Methods for further details. Speci® c activity in the absence of inhibitor was 12.4 nmoles HCHO/min/nmole SLO. Inhibition of imipramine N -demethylation in each case was concentration dependent and only selected data are reported. The values given are mean of two or more separate experiments. desipramine undergoes further oxidation was addressed directly by incubating SLO with 2.5 mM desipramine in the presence of H 2 O 2 . Although positive results were obtained (Table 2) , the formaldehyde production rate from desipramine was only » 20% of the rate noted for imipramine. The ability of SLO to metabolize other related antidepressants was also evaluated. The data obtained (Table 2) clearly indicated that trimipramine is the best substrate. The formaldehyde accumulation in the reaction media was relatively low when other drugs were employed as the substrates for N -demethylation by SLO. Assays were performed at 37 ± C for 30 minutes using incubation medium (1.0 ml ® nal volume) containing 200 nM SLO, 2.5 mM indicated substrate, and 0.5 mM H 2 O 2 in 50 mM phosphate buffer, pH 6.5. See Materials and Methods for further details.
DISCUSSION
In recent years, SLO has been increasingly used as a model enzyme in studies on xenobiotic metabolism. Kulkarni and Cook (1988b) were the ® rst to report oxidation of xenobiotics by SLO in the presence of H 2 O 2 . The peroxidative mode of xenobiotic metabolism by SLO does not appear to be restricted to the model substrates examined (Kulkarni and Cook 1988b; Kulkarni et al. 1989 ) because subsequent studies have revealed the ability of this enzyme to oxidize many other chemicals. Thus, reports are now available on the oxidation of catecholamines (Rosei et al. 1994 ), phenothiazines (Perez-Gilabert, Sanchez-Ferrer, and Garcia-Carmona 1994a , 1994b , isoproterenol (Nunez-Delicado et al. 1996 ), 4-aminobiphenyl (Datta et al. 1997 ), aminopyrine (Perez-Gilabert, Sanchez-Ferrer, and Garcia-Carmona 1997 Yang and Kulkarni 1998) , and pesticides (Hu and Kulkarni 1998) by SLO in the presence of H 2 O 2 .
In general, the N -dealkylation of xenobiotics leads to detoxication of the parent compound. However, this is not true in the case of tricyclic antidepressants because demethylated metabolites retain substantial pharmacological activity. In the present study, the formaldehyde accumulation in the incubation media as a result of imipramine N -demethylation was found to depend on the incubation time, amount of enzyme, concentration of substrate and H 2 O 2 ( Figures 2A±D) . Formaldehyde was not produced when any one of these components was omitted from the reaction medium. Collectively, the results suggest an enzymatic nature of the reaction. The inhibition of the reaction by NDGA (Table 1) provides an additional con® rmatory evidence for the involvement of LO.
Our earlier ® ndings (Kulkarni and Cook 1988b; Kulkarni et al. 1989 ) suggested that the pH optimum for xenobiotic oxidation by SLO in the presence of H 2 O 2 may be unique for each substrate. Thus, the 3,3 0 ,5,5 0 -tetramethylbenzidine oxidation rate was found to be highest at pH 5.7 (Kulkarni and Cook 1988b) . The rate of oxidation of 2,2 0 -azino-bis(3-ethylbenzothiazolinesulfonic acid) (ABTS), benzidine, guaiacol, and pyrogallol was reported to be several fold higher at pH 6.0 as compared to that noted at pH 9.0, whereas reverse was true for N, N, N 0 , N 0tetramethyl-1,4-phenylenediamine (Kulkarni et al. 1989 ). Rosei et al. (1994) noted that dopachrome formation from dopa by SLO in the presence of H 2 O 2 occurs maximally at pH 8.5. According to Perez-Gilabert, Sanchez-Ferrer, and Garcia-Carmona (1994a , 1994b , a pH of 3.0±3.5 was required to observe a maximum rate of phenothiazine oxidation, whereas pH 6.0 was favored by SLO-catalyzed isoproterenol (Nunez-Delicado et al. 1996) and 4-aminobiphenyl (Datta, Sherblom, and Kulkarni 1997) oxidation. Similar acidic pH requirement was also noted for the N -demethylation of aminopyrine (Perez-Gilabert, Sanchez-Ferrer, and Garcia-Carmona 1997; Yang and Kulkarni 1998) and pesticides (Hu and Kulkarni 1998) by SLO in the presence of H 2 O 2 . Our observation that imipramine N -dealkylation displays an optimum pH of 6.5 is in accord with these reports. In general, xenobiotic substrates undergoing LO-mediated oxidation in the presence of H 2 O 2 exhibit low af® nity toward enzyme. In this regard, the reported values for K M range from 0.62 to 4.63 mM for catecholamines (Rosei et al. 1994 ), 1.4 to 8.5 mM for phenothiazines (Perez-Galabert, Sanchez-Ferrer, and Garcia-Carmona 1994a, 1994b) , and 26 mM for isoproterenol (Nunez-Delicado et al. 1996) . Similarly, for N -demethylation, the reported values range from 3.4 mM for aminocarb (Hu and Kulkarni 1998) to 85 mM for aminopyrine (Perez-Gilabert, Sanchez-Ferrer, and Garcia-Carmona 1997) . In this regard, the estimated value of 0.66 mM for imipramine suggests that it may be one of the best substrates for N -demethylation by SLO. In contrast to xenobiotic substrates, several studies have shown that SLO exhibits relatively high af® nity toward H 2 O 2 . The reported K M values for H 2 O 2 are 71.4 l M for dopa oxidation (Rosei et al. 1994) , 94 l M for isoproterenol oxidation (Nunez-Delicado et al. 1996) , and range from 50 l M to 1.2 mM for oxidation of different phenothiazines (Perez-Galabert, Sanchez-Ferrer, and Garcia-Carmona 1994a, 1994b) . The K M value of 116 l M noted in this study for imipramine dealkylation isclearly in accord with these reports.
The generation of an initial cation free radical from xenobiotic substrates undergoing N -dealkylation is a common attribute noted during peroxidative oxidation of xenobiotics catalyzed by horseradish peroxidase and other peroxidases (Grif® n and Ting 1978; Lasker et al. 1981) . Recent studies with SLO have also pointed out the generation of a cation free radical species as an initial intermediate during the N -demethylation of aminopyrine (Perez-Gilabert, Sanchez-Ferrer, and Garcia-Carmona 1997; Yang and Kulkarni 1998) . A similar free radical intermediate was postulated in the N -dealkylation of aminocarb and other pesticides (Hu and Kulkarni 1998) . Although electron spin resonance (ESR) studies were not conducted and, therefore, the precise mechanism involved remains an open issue, it is believed that a free radical intermediate is initially produced during imipramine N -demethylation by SLO. Thiscontention ® nds further support in the strong suppressive response observed in the presence of BHT or BHA (Table 1) . A signi® cant blockade of formaldehyde accumulation by the inclusion of reducing agents such as GSH and DTT in the reaction media (Table 1) is clearly in accord with this proposition, because these chemicals are expected to reduce the radical species back to the parentcompound.
Desipramine, the expected product of imipramine mono N -demethylation, was identi® ed as the metabolite isolated from the reaction mixture (Figure 3) . The HPLC pro® les did not reveal the presence of the metabolite of imipramine didemethylation. This may be related to a relatively small amount of the metabolite generated during the incubation and/or a lack of sensitivity of the detection method used. To understand further this aspect, assays were performed directly with desipramine under optimum conditions developed for imipramine oxidation. The results of these experiments clearly suggest that easily measurable amount of formaldehyde is generated when SLO is incubated with a relatively higher concentration of desipramine (2.5 mM) in the presence of H 2 O 2 (Table 2) . However, as compared to imipramine, the rate of formaldehyde production from desipramine was much lower (only » 20%) ( Table 2) . Taken together, these results suggest that both imipramine and desipramine undergo this N -demethylation process. Considering the inherent complexity associated with simultaneous reactions, no attempt was made to establish the stoichiometry of imipramine oxidation.
Under the assay conditions employed, SLO exhibited a marked substrate speci® city for N -dealkylation and not all the antidepressant drugs tested were oxidized at the same rate. In contrast to both imipramine and trimipramine which were easily oxidized, N -demethylation of the other substrates occurred at a relatively low rate. Although other explanations are possible, these observations suggest that the presence of the nitrogen atom at position 5 in imipramine and trimipramine molecules plays a crucial facilitative role in the binding of substrate to the enzyme. This may perhaps explain why amitriptyline and doxepin are poorly metabolized under identical assay conditions. The presence of an additional methyl group in the alkyl side chain in the molecule of trimipramine improves further the enzyme-substrate interaction. As a result, an enhanced rate of N -demethylation of trimipramine was observed as compared to that noted with imipramine. An addition of a chlorine atom in the molecule as in the case of clomipramine or other substituents (e.g., diltiazem) apparently interfered with the enzyme substrate complex formation and dramatically reduced the ability of these chemicals to serve as substrates for oxidation by SLO.
The N -dealkylation of imipramine has been extensively studied in the mammalian liver and the role of P450 in this reaction is well established. According to Lemoine et al. (1993) , P450 1A2 and P450 3A4 are the major isozymes responsible for the NADPH-dependen t N -demethylation of imipramine in human liver microsomes. The authors reported V max values of < 1.2 nmol/min/nmol P450 and 0.6 nmol/min/mg microsomal protein. In the present investigation, we observed a rate of 14±18 nmol formaldehyde produced/min/nmol SLO or 133±164 nmol formaldehyde produced/min/mg protein for imipramine N -demethylation by SLO in the presence of H 2 O 2 . This clearly suggests that, in addition to P450, LO may be another ef® cient catalyst in mediating the N -dealkylation of imipramine.
Although biotransformation in the liver mainly determines the biological half-life of imipramine, it is not the target tissue for the pharmacological action. In the brain, the primary target organ for the pharmacological action, the magnitude of imipramine metabolism is expected to be relatively small, because the brain P450 content is only 0.6% of the liver (Ghersi-Egea et al. 1989 ). The observations reported by Sequeira and Strobel (1995) clearly support this view. These authors reported the rate of desipramine formation from imipramine in rat brain microsomes to be only about 0.35% of the rate observed with hepatic microsomes. In contrast to the P450 pathway, easily measurable LO activity occurs in rat brain (Naidu, Naidu, and Kulkarni 1992; Byczkowski, Ramgoolie, and Kulkarni 1992) . A similar situation exists for the human placenta, a reproductive tissue representing a potential target for imipramine toxicity.
The P450 capable of xenobiotic oxidation in the placentas of nonsmokers is practically undetectable (Juchau 1995; Kulkarni 1996) and, therefore, the contribution of this pathway to the N -demethylation of these drugs is not expected to be of any biological signi® cance. MFO is also absent in human placenta (Kulkarni 1996) . However, LO is plentiful (Joseph, Srinivasan, and Kulkarni 1993; Datta and Kulkarni 1994; Datta, Sherblom, and Kulkarni 1997) and can utilize H 2 O 2 to effect xenobiotic cooxidation (Datta, Sherblom, and Kulkarni 1997) . Because all the reactions noted with SLO have previously been shown to occur with animal or human tissue LOs (Kulkarni 1996) , it is tempting to speculate that this enzymatic pathway may be involved in the biotransformation of these drugs in the mammalian extrahepatic tissues such as brain and placenta. Further studies are clearly warranted to con® rm or refute this postulate.
